Dimitrios Mariglis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Dimitrios Mariglis has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Anastasios Kollias
Hypertension Center STRIDE-7, National and Kapodistrian University of Athens, School of Medicine, Third Department of Medicine, Sotiria Hospital, Athens, Greece
2 shared publications - Ariadni Menti
Hypertension Center STRIDE-7, School of Medicine, Third Department of Medicine, Sotiria Hospital, National and Kapodistrian University of Athens, Athens, Greece
2 shared publications - George S. Stergiou
Hypertension Center STRIDE-7, National and Kapodistrian University of Athens, School of Medicine, Third Department of Medicine, Sotiria Hospital, Athens, Greece
2 shared publications - Aikaterini Komnianou
Hypertension Center STRIDE‐7, National and Kapodistrian University of Athens, School of Medicine, Third Department of Medicine, Sotiria Hospital
1 shared publication - Aletta Elisabeth Schutte
North‐West University
1 shared publication - Eirini-Chrysovalanti Antonogiannaki
Hypertension Center STRIDE‐7, National and Kapodistrian University of Athens, School of Medicine, Third Department of Medicine, Sotiria Hospital
1 shared publication
Latest Publications
- 1 September 2026
- Published by Wolters Kluwer Health in Hypertension
- Vol. 83 (9)
Validated Automated Cuff Blood Pressure Devices for Children: STRIDE BP Report and Call to Action
BACKGROUND: Similar to adults, in children automated cuff devices are recommended for office, home, and ambulatory blood pressure (BP) measurement. However, a device validated in adults may not be accurate in children, and separate investigation is necessary. Moreover, current pediatric guidelines recommend hypertension detected by an automated device to be confirmed using auscultation. The evidence on validated automated BP devices for children (aged 3–12 years) is presented. METHODS: STRIDE BP ( www.stridebp.org ) performs periodic systematic PubMed searches for validation studies of automated BP devices. The data set of studies including children was analyzed. RESULTS: Fifty-one of 628 studies in the STRIDE BP database included children. Forty-one (80%) concluded that the test device passed the validation, yet due to protocol violations STRIDE BP approved 22 of them (43%). These 22 studies validated 20 devices (14 on the market). Seven additional devices had measurement functions equivalent to STRIDE BP-approved devices (6 on the market). Meta-analysis of 20 successful studies including children and older individuals (N=1476) showed a pooled test-reference systolic BP difference of 0.6 mm Hg (95% CI, −0.2 to 1.4), and diastolic −0.3 (95% CI, −1.2 to 0.6). Meta-analysis of 7 studies including only children (N=410) showed a pooled difference of 1.0 (95% CI, −0.7 to 2.8)/−1.3 (95% CI, −2.9 to 0.4) mm Hg. CONCLUSIONS: There is a severe shortage of validated automated BP devices for children, with published studies often having methodological issues. Some devices are validated in children and, as in adults, can replace auscultatory devices for office hypertension diagnosis. There is an urgent need for more automated BP devices to be validated in children.
- 1 September 2026
- Published by Wolters Kluwer Health in Hypertension
- Vol. 83 (9)
Validated Automated Cuff Blood Pressure Devices for Children: STRIDE BP Report and Call to Action
BACKGROUND: Similar to adults, in children automated cuff devices are recommended for office, home, and ambulatory blood pressure (BP) measurement. However, a device validated in adults may not be accurate in children, and separate investigation is necessary. Moreover, current pediatric guidelines recommend hypertension detected by an automated device to be confirmed using auscultation. The evidence on validated automated BP devices for children (aged 3–12 years) is presented. METHODS: STRIDE BP ( www.stridebp.org ) performs periodic systematic PubMed searches for validation studies of automated BP devices. The data set of studies including children was analyzed. RESULTS: Fifty-one of 628 studies in the STRIDE BP database included children. Forty-one (80%) concluded that the test device passed the validation, yet due to protocol violations STRIDE BP approved 22 of them (43%). These 22 studies validated 20 devices (14 on the market). Seven additional devices had measurement functions equivalent to STRIDE BP-approved devices (6 on the market). Meta-analysis of 20 successful studies including children and older individuals (N=1476) showed a pooled test-reference systolic BP difference of 0.6 mm Hg (95% CI, −0.2 to 1.4), and diastolic −0.3 (95% CI, −1.2 to 0.6). Meta-analysis of 7 studies including only children (N=410) showed a pooled difference of 1.0 (95% CI, −0.7 to 2.8)/−1.3 (95% CI, −2.9 to 0.4) mm Hg. CONCLUSIONS: There is a severe shortage of validated automated BP devices for children, with published studies often having methodological issues. Some devices are validated in children and, as in adults, can replace auscultatory devices for office hypertension diagnosis. There is an urgent need for more automated BP devices to be validated in children.
- Open Access
- 16 June 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (12) , e047764
Routine Handheld Carotid Ultrasonography for Cardiovascular Risk Stratification and Primary Prevention Treatment Decisions in a Contemporary Middle‐Aged General Population
- 16 June 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (12) , e047764
Open AccessRoutine Handheld Carotid Ultrasonography for Cardiovascular Risk Stratification and Primary Prevention Treatment Decisions in a Contemporary Middle‐Aged General Population